Endothelial NF-?B Blockade Abrogates ANCA-Induced GN.
Ontology highlight
ABSTRACT: ANCA-associated vasculitis (AAV) is a highly inflammatory condition in which ANCA-activated neutrophils interact with the endothelium, resulting in necrotizing vasculitis. We tested the hypothesis that endothelial NF-?B mediates necrotizing crescentic GN (NCGN) and provides a specific treatment target. Reanalysis of kidneys from previously examined murine NCGN disease models revealed NF-?B activation in affected kidneys, mostly as a p50/p65 heterodimer, and increased renal expression of NF-?B-dependent tumor necrosis factor ? (TNF-?). NF-?B activation positively correlated with crescent formation, and nuclear phospho-p65 staining showed NF-?B activation within CD31-expressing endothelial cells (ECs) in affected glomeruli. Therefore, we studied the effect of ANCA on NF-?B activation in neutrophil/EC cocultures in vitro ANCA did not activate NF-?B in primed human neutrophils, but ANCA-stimulated primed neutrophils activated NF-?B in ECs, at least in part via TNF-? release. This effect increased endothelial gene transcription and protein production of NF-?B-regulated interleukin-8. Moreover, upregulation of endothelial NF-?B promoted neutrophil adhesion to EC monolayers, an effect that was inhibited by a specific IKK? inhibitor. In a murine NCGN model, prophylactic application of E-selectin-targeted immunoliposomes packed with p65 siRNA to downregulate endothelial NF-?B significantly reduced urine abnormalities, renal myeloid cell influx, and NCGN. Increased glomerular endothelial phospho-p65 staining in patients with AAV indicated that NF-?B is activated in human NCGN also. We suggest that ANCA-stimulated neutrophils activate endothelial NF-?B, which contributes to NCGN and provides a potential therapeutic target in AAV.
SUBMITTER: Choi M
PROVIDER: S-EPMC5661273 | biostudies-literature | 2017 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA